Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

QVMM

Invesco S&P MidCap 400 QVM Multi-factor ETF (QVMM)

Rating:72Outperform
Price Target:$38.00â–²(9.59% Upside)

QVMM, the Invesco S&P MidCap 400 QVM Multi-factor ETF, is supported by several strong mid-cap holdings with solid financial performance and generally positive outlooks, which together point to a well-built, quality fund. Standout positions like United Therapeutics, Royal Gold, ATI, TechnipFMC, and Woodward contribute positively through robust revenue growth, healthy balance sheets, and bullish technical trends, while names such as XPO and ITT introduce some caution due to high leverage, legal or valuation concerns, and potential short-term technical weakness. The main risk factor is that many top holdings share similar issues around higher valuations and occasional overbought conditions, which could make the fund more sensitive to market pullbacks.

Positive Factors
Strong Top Holdings PerformanceMany of the largest positions have shown strong gains this year, helping support the ETF’s overall results.
Broad Sector DiversificationThe fund spreads its investments across many sectors like industrials, financials, technology, health care, and energy, which helps reduce the impact of weakness in any single industry.
Low Expense RatioThe ETF charges relatively low annual fees, which means more of the fund’s returns stay in investors’ pockets over time.
Negative Factors
Recent Short-Term WeaknessThe ETF has shown weak performance over the last one and three months, which may signal near-term volatility or pressure on mid-cap stocks.
Heavy U.S. Market DependenceWith almost all assets in U.S. companies and very little in Canada, the fund’s returns are highly sensitive to the U.S. economy and stock market.
Limited Single-Stock CushionAlthough no single holding is very large, the fund’s performance can still be affected if several of its mid-sized positions weaken at the same time.

QVMM vs. SPDR S&P 500 ETF (SPY)

-5%0%5%10%15%20%25%30%SPY+14.55%QVMM+19.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
423.67M
Region
North America
Expense Ratio
0.15%
Beta
0.84
Issuer
Invesco
Inception Date
Jun 30, 2021
Dividend Yield
1.25%
Asset Class
Equity
Index Tracked
S&P MidCap 400 Quality, Value & Momentum Top 90% Multi-factor Index (USD)

QVMM Summary

The Invesco S&P MidCap 400 QVM Multi-factor ETF (QVMM) invests in medium-sized U.S. companies and follows the S&P MidCap 400 Quality, Value & Momentum Index. It focuses on businesses that look financially strong, reasonably priced, and showing positive stock trends. The fund spreads money across many sectors, including industrials, financials, technology, and health care, and holds well-known names like Okta and United Therapeutics. Someone might invest in QVMM to tap into the growth potential of mid-sized companies while diversifying beyond large caps. A key risk is that mid-cap stocks can be more volatile and can go up and down with the overall stock market.

How much will it cost me?

This ETF has an expense ratio of 0.15%, which means you’ll pay about $1.50 per year for every $1,000 you invest. That cost is slightly below average for a specialized, rules-based ETF, because while it uses a multi-factor strategy, it still tracks an index rather than being fully actively managed.

What would affect this ETF?

This U.S. mid-cap ETF could benefit if the economy grows steadily, supporting industrial, technology, and consumer cyclical companies, and if investors favor quality, value, and momentum strategies. On the downside, higher interest rates, economic slowdowns, or sector-specific issues in areas like financials, health care, or real estate could hurt its holdings and weigh on future performance.

QVMM Top 10 Holdings

QVMM is a U.S.-focused mid-cap fund where a handful of industrials, health care, and tech names set the tone. Okta and Entegris have been rising, giving the ETF a lift from the technology side, while United Therapeutics and Tenet Healthcare add steady strength from health care. On the industrial front, Reliance Steel has been climbing, but ATI and nVent Electric have turned more mixed to lagging lately, occasionally acting as a speed bump. Overall, the fund leans into cyclical, domestically driven growth stories rather than global mega-cap tech.

QVMM top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
FTIFTITechnipFMC0.86%$3.64M$25.76B53.52%80Outperform
USFDUSFDUS Foods Holding0.83%$3.52M$23.28B50.35%74Outperform
UTHRUTHRUnited Therapeutics0.82%$3.46M$25.18B27.88%79Outperform
ATIATIATI0.80%$3.39M$24.87B85.77%78Outperform
THCTHCTenet Healthcare0.79%$3.34M$22.76B45.44%74Outperform
XPOXPOXPO0.77%$3.27M$22.46B42.33%70Outperform
ENTGENTGEntegris0.69%$2.92M$22.52B81.85%66Neutral
RGLDRGLDRoyal Gold0.68%$2.86M$21.72B35.58%78Outperform
RSRSReliance Steel0.69%$2.91M$21.77B56.27%74Outperform
WWDWWDWoodward0.64%$2.71M$19.48B25.28%79Outperform

QVMM Technical Analysis

Technical Analysis SentimentPositive
Last Price34.67

Price Trends

50DMA34.20Positive
100DMA34.86Negative
200DMA34.07Positive

Market Momentum

MACD0.16Negative
RSI53.42Neutral
STOCH80.31Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QVMM, the sentiment is Positive. The current price of 34.67 is above the 20-day moving average (MA) of 34.35, above the 50-day MA of 34.20, and above the 200-day MA of 34.07, indicating a bullish trend. The MACD of 0.16 indicates Negative momentum. The RSI at 53.42 is Neutral, neither overbought nor oversold. The STOCH value of 80.31 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QVMM.

QVMM Peer Comparison

Comparison Results

QVMM against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
QVMMQVMM$34.67$38.00(9.59% Upside)$423.67M0.15%72Outperform
EZMEZM$75.60$88.10(16.53% Upside)$950.99M0.38%70Neutral
XMLVXMLV$67.05$73.66(9.86% Upside)$730.22M0.25%71Outperform
BKMCBKMC$39.52$48.57(22.89% Upside)$651.75M0.04%68Neutral
GRPMGRPM$144.92$162.71(12.27% Upside)$611.74M0.35%74Outperform
AVMCAVMC$79.25$93.90(18.48% Upside)$558.86M0.18%70Outperform

Performance Comparison

0%10%20%30%QVMMEZMXMLVBKMCGRPMAVMCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
QVMM and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
QVMMInvesco S&P MidCap 400 QVM Multi-factor ETF34.675.7419.84%
EZMWisdomTree U.S. MidCap Fund75.6012.7920.36%
XMLVInvesco S&P MidCap Low Volatility ETF67.056.8411.36%
BKMCBNY Mellon US Mid Cap Core Equity ETF39.525.3015.47%
GRPMInvesco S&P MidCap 400 GARP ETF144.9231.1427.36%
AVMCAvantis U.S. Mid Cap Equity ETF79.2512.4118.56%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.